4th EPHA Universal Access and Affordable Medicines Forum

Time for a New Deal: Challenging the status quo on medicines policy

The annual one-day multi-stakeholder Forum on access to medicines in Europe organised
by the European Public Health Alliance.

The 4th EPHA Universal Access and Affordable Medicines Forum provided stimulating and lively discussions on the hottest topics in the access to medicines debate, including: pharma and medicines policies, affordability, R&D (research and development), innovation, transparency in pharmaceuticals, shortages, patient safety, health technology assessment (HTA).

#newdeal4meds

speakers

participants

Twitter reach

Programme

DOWNLOAD THE PROGRAMME

09:30 - 09:45 Welcome and introduction

Fiona Godfrey, Secretary General, European Public Health Alliance (EPHA) @fjgodfrey @EPHA_EU

09:45 - 11:10 EU plans around cancer: Hype VS substance

Denis Lacombe, Director-General, European Organisation for Research and Treatment of Cancer (EORTC) @EORTC
Kathi Apostolidis, President, European Cancer Patient Coalition (ECPC) @cancereu @kgapo
Carin Uyl-de Groot, Professor, Health Technology Assessment, Director of the Institute for Medical Technology Assessment (iMTA), School of Health Policy & Management, Erasmus University Rotterdam @ESHPM_EUR
Ward Rommel, Researcher, Kom op tegen Kanker, Access to Medicines Task-Force,
European Cancer Leagues (ECL) @CancerLeagues @KOTKanker @WardRommel
Chantal Bélorgey, Head of the Health Technology Assessment (HTA) and Public Health division, French Health Authority (Haute Autorité de Santé – HAS) @HAS_sante

11:30 - 12:00 Access to medicines – high and unsustainable price levels: Keynote & brief exchange with Bjørn-Inge Larsen

Bjørn-Inge Larsen, Secretary-General, Ministry of Health and Care Services, Norway
Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines, European Public Health Alliance (EPHA), Member Of The Management Board at European Medicines Agency (EMA) @ynatsis @EPHA_EU

13:00-14:25 An old new problem: Solutions to the medicines shortages in Europe

Vlad Mixich, Coordinator, Romanian Health Observatory – Board member, EPHA @mixich
Charlotte Roffiaen, EU advocacy advisor, France Assos Santé (FAS) @Fr_Assos_Sante @EU4Ublog
Aida Batista, Vice-President, European Association of Hospital Pharmacists (EAHP) @EAHPtweet @AidaBatista
Kasper Ernest, Secretary-General, European Association of Euro-Pharmaceutical Companies (EAEPC) @EAEPC_Brussels @KasperErnest

14:45-16:15 Pharmaceuticals, a secretive business: How to shed light into the black box?

Ellen t’ Hoen LLM, PhD, Medicines Law & Policy @MedsLawPolicy @ellenthoen
Audun Hågå, Head, Norwegian Medicines Agency
Marcel van Raaij, Director of Pharmaceutical Affairs and Medical Technology, Ministry of Health, Welfare, and Sports, The Netherlands @MarcelvanRaaij
Fergal O’ Regan, Head of Enquiries, European Ombudsman @EUombudsman
Alexander Roediger, Executive Director Oncology Policy, Europe, Middle East, Africa and Canada (EMEAC), MSD International @MSDInvents

16:15-16:30 Closing remarks

16:30-17:30 Networking reception

Event Gallery

In the Press

Speakers

Aida Batista

Vice-President, European Association of Hospital Pharmacists (EAHP)

Charlotte Roffiaen

EU advocacy advisor, France Assos Santé (FAS)

Rohit Malpani

Board member, UNITAID

Ward Rommel

Access to Medicines Task-Force, European Cancer Leagues (ECL)

Fergal O' Reagan

European Ombudsman

Audun Hågå

Head, Norwegian Medicines Agency

Alexander Roediger

MSD International

Fiona Godfrey

European Public Health Alliance (EPHA)

Kathi Apostolidis

President, European Cancer Patient Coalition (ECPC)

Marcel van Raaij

Director of Pharmaceutical Affairs and Medical Technology, Ministry of Health, Welfare, and Sports, The Netherlands

Bjørn-Inge Larsen

Secretary-General, Ministry of Health and Care Services, Norway

Chantal Bélorgey

Head of the Health Technology Assessment (HTA) and Public Health division, French Health Authority (Haute Autorité de Santé - HAS)

(tbc)

Ellen t’ Hoen LLM, PhD

Medicines Law & Policy

Vlad Mixich

Coordinator, Romanian Health Observatory – Board member, EPHA

Carin Uyl-de Groot

Professor, Health Technology Assessment, Director of the Institute for Medical Technology Assessment (iMTA), School of Health Policy & Management, Erasmus University Rotterdam

Denis Lacombe

Director-General, European Organisation for Research and Treatment of Cancer (EORTC)

Yannis Natsis